Somatomedin C in pediatric pathophysiology.

Area of Science:

• Endocrinology
• Pediatric Growth Disorders

Background:

• Human growth involves two primary somatomedin peptides: insulin-like growth factor I (IGF I), also known as somatomedin C (SmC), and IGF II.
• IGF II's role in postnatal growth appears minimal, with IGF I/SmC being the focus for growth assessment.

Purpose of the Study:

• To evaluate the utility of IGF I/SmC assays in identifying growth hormone (GH)-deficient subjects.
• To explore the diagnostic limitations of IGF I/SmC assays in pediatric populations.

Main Methods:

• Utilized IGF I/SmC assays to assess patients.
• Compared IGF I/SmC values between GH-deficient subjects and normal children.
• Considered short children with normal GH release but low SmC values.

Main Results:

• Significant overlap in IGF I/SmC values between GH-deficient and normal children prevents effective screening for pituitary disorders.
• Low SmC values were observed in some short children with normal GH release, suggesting potential limitations in traditional GH testing.

Conclusions:

• IGF I/SmC assays are not suitable for screening GH deficiency in children due to overlapping values.
• The assay is highly valuable for diagnosing and monitoring acromegaly treatment.
• Further investigation is needed for short children with normal GH release but low SmC.